Skip to content

1Day Sooner

    • Volunteer
    • What is a Challenge Study?
    • Meet 1Day Volunteers
    • Participant Council
    • Informed Consent Guide
    • Recruiting Challenge Studies
    • About 1Day Sooner
    • 1Day Sooner Team
    • Finances & Transparency
    • Careers
  • Events
  • CPO Investigator Hub
    • Study Support for Investigators
    • Frequently Asked Questions
    • Public & Patient Involvement Alignment
    • Case Studies
      • Malawi Liverpool Wellcome Research Programme
      • Hepatitis C Human Challenge Trial
    • 1Day Sooner Blog
    • 1Day Sooner in the News
    • Newsletters
    • Press Releases
    • Research & Publications
    • Briefs & Reports
    • Challenge Study Compendium
    • Target Product Profile Design
    • Volunteer Support
    • Clinical Trial Abundance
    • Pandemic Preparedness
    • Pandemic Insurance Fund
    • Challenge Model Development
      • Group A Strep
      • Tuberculosis
      • Hepatitis C Human Challenge Studies
  • Contact Us
  • Merch
  • 1Day Africa
  • 1Day UK
  • Find 1Day Sooner on Facebook
  • Find 1Day Sooner on Instagram
  • Find 1Day Sooner on Twitter
  • Find 1Day Sooner on YouTube
Donate
Donate
  • Malaria

    March 4, 2024

    How do the design and structure of the RTS,S and R21 malaria vaccines compare?

    By 1Day Sooner’s Ryan Duncombe, PhD. The following expands on information in 1Day Africa’s R21 Status Report. Understanding the structure and…

  • Malaria

    February 21, 2024

    R21 Vaccine Cost Estimates

    Estimating the cost of delivering the R21/Matrix-M malaria vaccine Author: David Tellett R21 vaccination: Costs and comparisons At the end…

  • Pandemic Preparedness

    February 21, 2024

    1Day Letter: Emerging Pandemic Preparedness Program FY2025 Appropriations

    Last year, 1Day Sooner coordinated a letter to the US Secretary of Health and Human Services in support of the…

  • HCV

    January 29, 2024

    1Day Sooner Launches Hepatitis C Forecasting Competition

    1Day Sooner is thrilled to launch a forecasting competition aimed at predicting the impact of human challenge trials in the…

  • Bioethics

    January 28, 2024

    How much is too much? Debating the ethics of paying medical research subjects

    In December 2023, 1Day Sooner co-hosted a parliamentary debate on the ethics of compensation for human research subjects.

  • Volunteers

    January 26, 2024

    What’s it like to be infected with malaria on purpose? Ask Paul!

    The R21 malaria vaccine was approved by the WHO in October 2023 and may well end up saving millions of…

  • Pandemic Preparedness

    December 8, 2023

    1Day Sooner Letter to OMB on FDA Emerging Pathogens Preparedness Program

    On September 26, 2023, 1Day Sooner delivered a letter to Health and Human Services Secretary Xavier Becerra outlining the case…

  • Pandemic Preparedness

    September 27, 2023

    1Day Letter: Establish the FDA Emerging Pathogens Preparedness Program

    The Emerging Pathogens Preparedness Program (EPPP) will allow the FDA to better defend against future emerging diseases.

  • Regulatory

    August 3, 2023

    Challenge Studies in India: 1Day Comment on ICMR’s Draft Document

    1Day Sooner supports developing human challenge studies (or controlled human infection studies, CHIS) in nations where target diseases, like malaria,…

  • Indoor Air Quality

    August 1, 2023

    Indoor Air Quality Report

    Download Air Safety to Combat Global Catastrophic Biorisk here. We did it for water — why can’t we do it for…

  • COVID-19

    April 19, 2023

    What is Project NextGen? Biden Administration’s Covid-19 Funding Plan

    In April, the White House launched a $5 billion program, Project NextGen, to accelerate the development of vaccines and treatments…

  • Bioethics

    April 17, 2023

    PEARL of Wisdom: Pandemic Preparedness & Prevention

    A full video of the event can be found here, and photos here. The next pandemic will not wait for…

  • Volunteers

    December 28, 2022

    Interview with Mallory A., Shigella (Dysentery) Challenge Volunteer

    With Jake Eberts, 1Day Sooner communications director Mallory A. volunteered for a trial testing a new vaccine for shigellosis, a…

  • COVID-19

    December 22, 2022

    Operation Warp Speed 2.0: More Than a Cool Name

    Enlli Lewis, Regulatory Policy and Research Coordinator at 1Day Sooner The United States’ Operation Warp Speed is one of the…

  • COVID-19

    December 1, 2022

    Covid-19 challenge trial media coverage in the UK was strongly positive

    Media in the United Kingdom approached human challenge trials for Covid-19 very positively.

  • Prev
  • Page 1
  • …
  • Page 3
  • Next

1Day Sooner

  • Contact Us
  • Merch
  • 1Day Africa
  • 1Day UK
  • Find 1Day Sooner on Facebook
  • Find 1Day Sooner on Instagram
  • Find 1Day Sooner on Twitter
  • Find 1Day Sooner on YouTube
Donate
  • Volunteer Hub
    • Volunteer
    • What is a Challenge Study?
    • Meet 1Day Volunteers
    • Participant Council
    • Informed Consent Guide
    • Recruiting Challenge Studies
  • About Us
    • About 1Day Sooner
    • 1Day Sooner Team
    • Finances & Transparency
    • Careers
  • Events
  • CPO Investigator Hub
    • Study Support for Investigators
    • Frequently Asked Questions
    • Public & Patient Involvement Alignment
    • Case Studies
      • Malawi Liverpool Wellcome Research Programme
      • Hepatitis C Human Challenge Trial
  • Media
    • 1Day Sooner Blog
    • 1Day Sooner in the News
    • Newsletters
    • Press Releases
  • Research
    • Research & Publications
    • Briefs & Reports
    • Challenge Study Compendium
    • Target Product Profile Design
  • Advocacy
    • Volunteer Support
    • Clinical Trial Abundance
    • Pandemic Preparedness
    • Pandemic Insurance Fund
    • Challenge Model Development
      • Group A Strep
      • Tuberculosis
      • Hepatitis C Human Challenge Studies
  • Privacy Policy

© 2026 1Day Sooner. All Rights Reserved. Site made in collaboration with CMYK